SWISS TAKEOVER BOARD

Current transactions

Offer

0825

MCH Group AG (2022)

Applicant: MCH Group AG
Applicant: Kanton Basel Stadt
Applicant: Lupa Investment Holdings, LP

Offer with unfriendly completion
Exception to mandatory offer
(Non-)existence of a mandatory offer
0823

Valora Holding AG (2022)

Offeror: Fomento Económico Mexicano, S.A.B. de C.V., Monterrey, Mexiko

Voluntary offer
Offer initially friendly
Cash offer
0822

Bobst Group SA (2022)

Offeror: JBF Finance SA, Buchillon, Switzerland

Voluntary offer
Offer initially friendly
Cash offer
0802

Vifor Pharma AG (2021)

Offeror: CSL Behring AG, Bern, Schweiz

Voluntary offer
Offer initially friendly
Cash offer

Obligation to make an offer (existence/exemptions)

0825

MCH Group AG (2022)

Applicant: MCH Group AG
Applicant: Kanton Basel Stadt
Applicant: Lupa Investment Holdings, LP

Offer with unfriendly completion
Exception to mandatory offer
(Non-)existence of a mandatory offer
0792

Idorsia Ltd (2021)

Applicant: Jean-Paul Clozel
Applicant: Martine Clozel

Exception to mandatory offer
0672

SHL Telemedicine Ltd. (2017)

Applicant: Nehama & Yoram Alroy Investment Ltd., Tel Aviv, Israel
Applicant: Elon Shalev, Tel Aviv, Israel

(Non-)existence of a mandatory offer

Buyback programmes

0821

SGS SA (2022)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0819

Geberit AG (2022)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0813

ABB Ltd. (2022)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0811

UBS Group AG (2022)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0803

Nestlé AG (2022)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0778

TEMENOS AG (2021)

Buyback programme
Exemption in reporting procedure
Buyback on regular line
0772

Geberit AG (2020)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0764

GAM Holding AG (2020)

Buyback programme
Exemption in reporting procedure
Buyback on regular line
Buyback on separate line
0761

Novartis AG (2020)

Buyback programme
Exemption in reporting procedure
Buyback on separate line